1
|
Haaser T, Lahmi L, Osman D, Gesbert C, Cheval V, Constantinides Y, de Crevoisier R, Dejean C, Escande A, Ghannam Y, Lorchel F, Thureau S, Lagrange JL, Durdux C, Huguet F. [Ethical stakes of information in radiation oncology: Thinking the risk and building the therapeutic alliance]. Cancer Radiother 2023; 27:480-486. [PMID: 37573195 DOI: 10.1016/j.canrad.2023.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Accepted: 06/07/2023] [Indexed: 08/14/2023]
Abstract
Informing patients before receiving radiation therapy is a fundamental ethical imperative. As a condition of the possibility of autonomy, information allows people to make health decisions concerning themselves, which is required by French law. This information includes in particular the potential risks due to radiation therapy. It is therefore necessary to think about what risk is, and how to define and assess it, in order to finally communicate it. The practice of informing people involves many ethical issues relating to the very content of the information, the form in which it is transmitted or even the intention that leads the health professional to say (or not to say) the risk. The transmission of information also questions the way to build a relationship of trust with the patients and how to integrate their own representations about these treatments. Between the risks of paternalism or even defensive medicine, this practice is at the heart of our professional practice.
Collapse
Affiliation(s)
- T Haaser
- Service d'oncologie radiothérapie, hôpital Haut Lévêque, centre hospitalier universitaire de Bordeaux, avenue Magellan, 33600 Pessac, France; Centre éthique et recherche en santé de Bordeaux, centre hospitalier universitaire de Bordeaux, Bordeaux, France; EA 4574 sciences, philosophie, humanités, universités de Bordeaux et Bordeaux Montaigne, Pessac, France.
| | - L Lahmi
- Service d'oncologie radiothérapie, institut Curie, Paris, France
| | - D Osman
- Service de médecine intensive-réanimation, hôpital de Bicêtre, AP-HP, DMU Correve, université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
| | - C Gesbert
- Direction de la qualité, des services aux patients et des parcours, centre hospitalier de Versailles, Versailles, France
| | - V Cheval
- Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, laboratoire CRIStAL, UMR9189, université de Lille, Lille, France
| | - Y Constantinides
- Espace éthique Île-de-France, Paris université Sorbonne Nouvelle, Paris, France
| | - R de Crevoisier
- Service d'oncologie radiothérapie, centre Eugène-Marquis, Rennes, France
| | - C Dejean
- Service d'oncologie radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France
| | - A Escande
- Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, laboratoire CRIStAL, UMR9189, université de Lille, Lille, France
| | - Y Ghannam
- Service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine UMR_S 938, institut universitaire de cancérologie, AP-HP, Sorbonne université, Paris, France
| | - F Lorchel
- Service d'oncologie radiothérapie, centre hospitalier universitaire Lyon-Sud, Lyon, France; Centre d'oncologie radiothérapie et oncologie de Mâcon (Orlam), Mâcon, France
| | - S Thureau
- Service d'oncologie radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France
| | - J L Lagrange
- Université Paris-Est Créteil Val-de-Marne, Paris, France
| | - C Durdux
- Service d'oncologie radiothérapie, hôpital européen Georges-Pompidou, Paris, France
| | - F Huguet
- Service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine UMR_S 938, institut universitaire de cancérologie, AP-HP, Sorbonne université, Paris, France
| |
Collapse
|
2
|
Stathakis S, Pissakas G, Alexiou A, Bertrand B, Bondiau P, Claude L, Cuthbert T, Damatopoulou A, Dejean C, Doukakis C, Güngör G, Hardy L, Maani E, Martel-Lafay I, Mavroidis P, Paragios N, Peppa V, Remonde D, Shumway J, Ugurluer G, Ozyar E. Evaluation of AI vs. Clinical Experts SBRT-Thorax Computed Tomography OARs Delineation. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
3
|
Marcié S, Gerard JP, Dejean C, Feuillade J, Gautier M, Montagné L, Fuentes C, Hannoun-Levi JM. The inverse square law: A basic principle in brachytherapy. Cancer Radiother 2022; 26:1075-1077. [PMID: 35843781 DOI: 10.1016/j.canrad.2022.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 04/02/2022] [Indexed: 11/28/2022]
Abstract
The purpose of this article is to remind the importance of the inverse square law in radiotherapy and especially in brachytherapy. Indeed, beyond the impact in radiation therapy with high energy beam, there is the use of radionuclides and low energy photons with short FSD where it is still more important. Comparisons between Iridium Brachytherapy and low energy X-rays brachytherapy show equivalent dose distributions in the first few centimeters. If the inverse square law is not the only element influencing the dose distributions calculations, it must not be forgotten. And it is playing a major role in brachytherapy with short FSD (<6cm).
Collapse
Affiliation(s)
- S Marcié
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| | - J P Gerard
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France.
| | - C Dejean
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| | - J Feuillade
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| | - M Gautier
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| | - L Montagné
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| | - C Fuentes
- Hospital Nuestra Senora-de-Candelaria, Tenerife, Spain
| | - J M Hannoun-Levi
- Radiotherapy Department, centre Antoine-Lacassagne, 33, avenue Valombrose, 06189 Nice cedex2, France
| |
Collapse
|
4
|
Abstract
We present the updated recommendations of the French society for radiation oncology on radiotherapy and pregnancy. The occurrence of cancer during pregnancy is a rare event (approximately 1 in 1000 pregnancies). The risks for the embryo or the foetus depend on the gestational age at the time of irradiation. The main risks are malformations with microcephaly and mental retardation. There is also a risk of radiation-induced cancer in the unborn child. In the case of only supradiaphragmatic irradiation, radiotherapy can be performed most often in pregnant women without risk to the foetus. On the other hand, in the case of an indication for subdiaphragmatic irradiation, therapeutic termination of the pregnancy should be proposed. In all cases, when radiotherapy is chosen, a phantom estimation of the dose delivered to the foetus, confirmed by in vivo measurement, is recommended. Conformational radiotherapy is the preferred technique because of the lower dose delivered to the foetus (except in tumour locations where other techniques such as IMRT are recommended).
Collapse
Affiliation(s)
- M Michalet
- Institut du cancer de Montpellier, 208, avenue des Apothicaires, 34298 Montpellier, France.
| | - C Dejean
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06100 Nice, France
| | - U Schick
- CHRU de Brest, 2, avenue Foch, 29200 Brest, France
| | - C Durdux
- Hôpital européen Georges-Pompidou, APHP, 20, rue Leblanc, 75015 Paris, France
| | - A Fourquet
- Institut Curie, 26, rue d'Ulm, 75005 Paris, France
| | - Y Kirova
- Institut Curie, 26, rue d'Ulm, 75005 Paris, France
| |
Collapse
|
5
|
Abstract
Penile cancers are uncommon and should be treated in expert center. Radiotherapy indications are mainly limited to exclusive brachytherapy for early stage penile glans cancer. Brachytherapy yields to excellent outcome for disease control and organ and function preservation. Only scarce data are available for external beam radiation therapy. It could be considered as palliative setting for irradiation of the primary tumor. For lymph node irradiation, external beam radiation therapy (with or without chemotherapy) could be discussed either as neoadjuvant approach prior to surgery for massive inguinal lymph node invasion or as adjuvant approach in case of high-risk of relapse. However, these cases should be discussed on an individual basis, as the level of evidence is poor. We present the recommendations of the French Society of Oncological Radiotherapy on the indications and techniques for external beam radiotherapy and brachytherapy for penile glans cancer.
Collapse
Affiliation(s)
- A Escande
- Département de radiothérapie, centre Oscar-Lambret, 3, avenue Frédéric-Combemale, 59000 Lille, France; Faculté de médecine Henri-Warembourg, université de Lille, 59000 Lille, France; Laboratoire Cristal, UMR 9189, 59009 Villeneuve-d'Ascq, France.
| | - D Peiffert
- Département d'oncologie radiothérapie, institut de cancérologie de Lorraine centre Alexis-Vautrin, 6, avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France
| | - C Dejean
- Département d'oncologie radiothérapie, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06000 Nice, France
| | - J-M Hannoun-Lévi
- Département d'oncologie radiothérapie, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06000 Nice, France
| | - A Cordoba
- Département de radiothérapie, centre Oscar-Lambret, 3, avenue Frédéric-Combemale, 59000 Lille, France
| | - P Pommier
- Département d'oncologie radiothérapie, centre Léon-Bérard, 28, rue Laennec, 69373 Lyon cedex 08, France
| | - C Haie-Méder
- Département d'oncologie radiothérapie, centre de cancérologie, Charlebourg la Défense, 65, avenue Foch, 92250 La Garenne Colombes, France
| | - C Chargari
- Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France; École du Val-de-Grâce, boulevard de Port-Royal, 75005 Paris, France; Département des effets biologiques des rayonnements, institut de recherche biomédicale des armées, 91223 Brétigny-sur-Orge, France
| |
Collapse
|
6
|
Khalladi N, Dejean C, Bosset M, Pointreau Y, Kinj R, Racadot S, Castelli J, Huguet F, Renard S, Guihard S, Tao Y, Rouvier JM, Johnson A, Bourhis J, Xu Shan S, Thariat J. A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients. Cancer Radiother 2021; 25:755-762. [PMID: 34565664 DOI: 10.1016/j.canrad.2021.04.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 04/19/2021] [Accepted: 04/28/2021] [Indexed: 11/25/2022]
Abstract
PURPOSE A Benchmark Case (BC) was performed as part of the quality assurance process of the randomized phase 2 GORTEC 2014-14 OMET study, testing the possibility of multisite stereotactic radiation therapy (SBRT) alone in oligometastatic head and neck squamous cell carcinoma (HNSCC) as an alternative to systemic treatment and SBRT. MATERIAL AND METHODS Compliance of the investigating centers with the prescription, delineation, planning and evaluation recommendations available in the research protocol was assessed. In addition, classical dosimetric analysis was supplemented by quantitative geometric analysis using conformation indices. RESULTS Twenty centers participated in the BC analysis. Among them, four major deviations (MaD) were reported in two centers. Two (10%) centers in MaD had omitted the satellite tumor nodule and secondarily validated after revision. Their respective DICE indexes were 0.37 and 0 and use of extracranial SBRT devices suboptimal There were significant residual heterogeneities between participating centers, including those with a similar SBRT equipment, with impact of plan quality using standard indicators and geometric indices. CONCLUSION A priori QA using a BC conditioning the participation of the clinical investigation centers showed deviations from good SBRT practice and led to the exclusion of one out of the twenty participating centers. The majority of centers have demonstrated rigorous compliance with the research protocol. The use of quality indexes adds a complementary approach to improve assessment of plan quality.
Collapse
Affiliation(s)
- N Khalladi
- Centre François Baclesse, 3, avenue General Harris, 14076 Caen, France
| | - C Dejean
- Centre Antoine Lacassagne, Nice, France
| | - M Bosset
- Centre Marie Curie, Valence, France
| | | | - R Kinj
- Centre Antoine Lacassagne, Nice, France
| | | | | | - F Huguet
- Centre hospitalier et universitaire Tenon, Paris, France
| | - S Renard
- Institut de Cancérologie de Lorraine, Nancy, France
| | - S Guihard
- Institut de Cancérologie Strasbourg Europe, Strasbourg, France
| | - Y Tao
- Institut Gustave Roussy, Villejuif, France
| | - J M Rouvier
- Centre hospitalier régional et universitaire, Besançon-Montbéliard, France
| | - A Johnson
- Centre François Baclesse, 3, avenue General Harris, 14076 Caen, France
| | - J Bourhis
- Centre hospitalier universitaire vaudois, Lausanne, Switzerland
| | - S Xu Shan
- Centre hospitalier universitaire vaudois, Lausanne, Switzerland
| | - J Thariat
- Centre François Baclesse, 3, avenue General Harris, 14076 Caen, France; Corpuscular Physics Laboratory-Normandy University, Caen, France.
| |
Collapse
|
7
|
Haaser T, Constantinides Y, Huguet F, De Crevoisier R, Dejean C, Escande A, Ghannam Y, Lahmi L, Le Tallec P, Lecouillard I, Lorchel F, Thureau S, Lagrange JL. [Ethical stakes in palliative care in radiation oncology]. Cancer Radiother 2021; 25:699-706. [PMID: 34400087 DOI: 10.1016/j.canrad.2021.07.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Accepted: 07/24/2021] [Indexed: 11/29/2022]
Abstract
In 2021, the Ethics Commission of the SFRO has chosen the issue of the practice of palliative care in radiotherapy oncology. Radiation oncology plays a central role in the care of patients with cancer in palliative phase. But behind the broad name of palliative radiotherapy, we actually find a large variety of situations involving diverse ethical issues. Radiation oncologists have the delicate task to take into account multiple factors throughout a complex decision-making process. While the question of the therapeutic indication and the technical choice allowing it to be implemented remains central, reflection cannot be limited to these decision-making and technical aspects alone. It is also a question of being able to create the conditions for a singularity focused care and to build an authentic care relationship, beyond technicity. It is through this daily ethical work, in close collaboration with patients, and under essential conditions of multidisciplinarity and multiprofessionalism, that our fundamental role as caregiver can be deployed.
Collapse
Affiliation(s)
- T Haaser
- Service d'Oncologie Radiothérapie, Hôpital Haut Lévêque, Centre Hospitalier Universitaire de Bordeaux, avenue Magellan, 33600 Pessac, France.
| | - Y Constantinides
- Espace Éthique Ile de France, Paris Université Sorbonne Nouvelle, Paris, France
| | - F Huguet
- Service d'Oncologie Radiothérapie, Hôpital Tenon, Centre de Recherche Saint-Antoine UMR_S 938, Institut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France
| | - R De Crevoisier
- Service d'Oncologie Radiothérapie, Centre Eugène Marquis, Rennes, France
| | - C Dejean
- Service d'Oncologie Radiothérapie, Unité de Physique Médicale, Centre Antoine Lacassagne, Nice, France
| | - A Escande
- Service universitaire d'Oncologie Radiothérapie, Centre Oscar Lambret, Faculté de médecine Henri Warembourg, Laboratoire CRIStAL, UMR9189, Université de Lille, Lille, France
| | - Y Ghannam
- Service d'Oncologie Radiothérapie, Hôpital Tenon, Centre de Recherche Saint-Antoine UMR_S 938, Institut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France
| | - L Lahmi
- Service d'Oncologie Radiothérapie, Hôpital Tenon, Centre de Recherche Saint-Antoine UMR_S 938, Institut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France
| | - P Le Tallec
- Service d'Oncologie Radiothérapie, Quantis Litis EA 4108, Centre Henri Becquerel, Rouen, France
| | - I Lecouillard
- Service d'Oncologie Radiothérapie, Centre Eugène Marquis, Rennes, France
| | - F Lorchel
- Service d'Oncologie Radiothérapie, Centre Hospitalier Universitaire Lyon-Sud, Lyon, France; Centre d'Oncologie Radiothérapie et Oncologie de Mâcon - ORLAM, Mâcon, France
| | - S Thureau
- Service d'Oncologie Radiothérapie, Quantis Litis EA 4108, Centre Henri Becquerel, Rouen, France
| | - J L Lagrange
- Université Paris-Est Créteil Val de Marne, Paris, France
| | | |
Collapse
|
8
|
Sumodhee S, Benezery K, Baron D, Natale R, Gautier M, Dejean C, Gérard J. PP-0165 Contact X-Ray Brachytherapy for eyelid carcinoma: Efficacy and toxicity in 69 patients. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06457-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
9
|
Jacques-Jamin C, Mias C, Ceruti I, Dejean C, Vantroeyen O, Filaquier C, Carballido F, Bessou-Touya S, Duplan H. 144 Barrier disruption and inflammatory skin models to evaluate cosmetic formulations on lipid metabolism. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Haaser T, Constantinidès Y, Dejean C, Escande A, Le Tallec P, Lorchel F, Marty S, Thureau S, Huguet F, Lagrange JL. [Health democracy: Patient partnership]. Cancer Radiother 2020; 24:736-743. [PMID: 32861610 DOI: 10.1016/j.canrad.2020.06.021] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2020] [Revised: 06/26/2020] [Accepted: 06/27/2020] [Indexed: 11/20/2022]
Abstract
In 2019, the scientific committee of the French society of radiation oncology (SFRO) created an ethics committee. Its mission is to provide our professional community with food for thought on ethical issues, and to identify its specificities within the radiation oncology departments. For the 2020 annual conference, the commission looked into the evolution of the patient-carer relationship, and more particularly to the strong idea of patient partnership. Indeed, the writing of the White Book of Cancer gave voice to sick people and stressed the need for new devices, such as the Caregiving Time. Patients can no longer be considered as objects of care but as people whose dignity and autonomy must be imperatively respected. The acquisition of knowledge allows a bilateral exchange, prerequisite of a dynamic collaboration. Patients can be partners in their own care, partners in training and research (expert patient), but also partners in health institutions and policies. It is this notion of partnership and involvement of the person in their path of care in radiation oncology that we will analyse here. It will be about defining it, by developing the concept of autonomy, and bringing out its complexity and ambivalence through two examples from our clinical practice: the shared decision-making process for patients with localized prostate cancer and the patient's involvement in the success of his radiotherapy.
Collapse
Affiliation(s)
- T Haaser
- Service de radiothérapie, hôpital Haut-Lévêque, centre hospitalier universitaire de Bordeaux, Pessac, France.
| | - Y Constantinidès
- Espace éthique Île-de-France, Paris Université Sorbonne Nouvelle, Paris, France
| | - C Dejean
- Service de radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France
| | - A Escande
- Service universitaire de radiothérapie, laboratoire CRIStAL, UMR9189, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, université de Lille, Lille, France
| | - P Le Tallec
- Service de radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France
| | - F Lorchel
- Centre de radiothérapie et oncologie de Mâcon - Orlam, Mâcon, France; Service de radiothérapie, centre hospitalier universitaire Lyon-Sud, Lyon, France
| | - S Marty
- Centre de coordination en cancérologie, centre hospitalier universitaire de Bordeaux, Pessac, France
| | - S Thureau
- Service de radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France
| | - F Huguet
- Service d'oncologie radiothérapie, centre de recherche Saint-Antoine UMR_S 938, Sorbonne université, hôpital Tenon, institut universitaire de cancérologie, AP-HP, Paris, France
| | - J-L Lagrange
- Université Paris-Est Créteil Val-de-Marne, Paris, France
| |
Collapse
|
11
|
Gérard JP, Dejean C, Montagne L, Benezery K, Doyen J, Hannoun Levi JM. A brief history of contact X-ray brachytherapy 50 kVp. Cancer Radiother 2020; 24:222-225. [PMID: 32171676 DOI: 10.1016/j.canrad.2020.01.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 01/22/2020] [Accepted: 01/25/2020] [Indexed: 11/18/2022]
Abstract
Contact X ray brachytherapy 50 kVp was initiated in the 1930s with the Siemens unit and popularized with the Philips unit in the 1950s. A renaissance was seen in the early 2000s with the Intrabeam™ unit for breast IORT. Presently the Papillon™ systems thanks to its high dose rate (>10Gy/mn) can be used to treat breast (IORT), skin, eyelid and rectal cancers. Future developments are expected to consolidate the place of contact radiotherapy as a safe and efficient treatment for accessible early tumors.
Collapse
Affiliation(s)
- J P Gérard
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France.
| | - C Dejean
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France
| | - L Montagne
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France
| | - K Benezery
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France
| | - J Doyen
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France
| | - J M Hannoun Levi
- Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France
| |
Collapse
|
12
|
Colnard-Hofverberg C, Gautier M, Dejean C, Feuillade J, Burgaud L, Mana A, Lhomel B, Hérault J. 65 Dosimetric measurements with Gafchromic EBT-3 films for the new 50kV Papillon+ intraoperative therapy system. Phys Med 2019. [DOI: 10.1016/j.ejmp.2019.09.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
13
|
Gérard JP, Bénézéry K, Barbet N, Dejean C, Coquard R, Montagné L. Préservation du rectum au cours des traitement des cancers de stade T2-3 : une conservation programmée est possible. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
14
|
Baron D, Sumodhee S, Natale R, Falk A, Doyen J, Claren A, Lagier J, Flores D, Dejean C, Feuillade J, Gautier M, Gérard JP, Bénézéry K. Efficacité et toxicité de la radiothérapie de contact par photons de 50 kV pour les carcinomes palpébraux. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
15
|
Mana A, Gautier M, Feuillade J, Burgaud L, Colnard C, Dejean C. 10 Preliminary evaluation on phantom for the transmission detector Delta4 Discover for the VMAT treatments. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.09.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
16
|
Dejean C, Gautier M, Ouakkad W, Lam Cham Kee D, Gérard J. EP-2235: Commissioning of the first Papillon + for breast intra operative radiotherapy unit. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)32544-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
17
|
Dejean C, Courrech F, Di Bartolo C, Ferre M, Gassa F, Pierrat N, Trafi M. 10. SFPM workgroup report: “New techniques and quality assurance in brachytherapy”. Phys Med 2017. [DOI: 10.1016/j.ejmp.2017.10.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
18
|
Gérard J, Dejean C, Chand M, Lam Cham Kee D, Doyen J, Benezery K, Hannoun-Levi J. EP-1766: First experiences using the new Papillon + TM Contact X-Ray Brachytherapy 50KVp (CXB) unit. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32128-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Dejean C, Gautier M, Feuillade J, Mana A. EP-1796: Definition of thresholds to detect anatomy changes using Delivery Analysis software for Tomotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33047-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Caron J, Feugeas JL, Dubroca B, Kantor G, Dejean C, Birindelli G, Pichard T, Nicolaï P, d'Humières E, Frank M, Tikhonchuk V. Deterministic model for the transport of energetic particles: Application in the electron radiotherapy. Phys Med 2015; 31:912-921. [PMID: 26701765 DOI: 10.1016/j.ejmp.2015.07.148] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2014] [Revised: 07/03/2015] [Accepted: 07/13/2015] [Indexed: 11/15/2022] Open
Abstract
A new deterministic method for calculating the dose distribution in the electron radiotherapy field is presented. The aim of this work was to validate our model by comparing it with the Monte Carlo simulation toolkit, GEANT4. A comparison of the longitudinal and transverse dose deposition profiles and electron distributions in homogeneous water phantoms showed a good accuracy of our model for electron transport, while reducing the calculation time by a factor of 50. Although the Bremsstrahlung effect is not yet implemented in our model, we propose here a method that solves the Boltzmann kinetic equation and provides a viable and efficient alternative to the expensive Monte Carlo modeling.
Collapse
Affiliation(s)
- J Caron
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France; Department of Radiotherapy, Institut Bergonie, Comprehensive Cancer Center, Bordeaux F-33076, France.
| | - J-L Feugeas
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - B Dubroca
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - G Kantor
- Department of Radiotherapy, Institut Bergonie, Comprehensive Cancer Center, Bordeaux F-33076, France
| | - C Dejean
- Department of Radiotherapy, Centre Antoine Lacassagne, Comprehensive Cancer Center, Nice F-06000, France
| | - G Birindelli
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - T Pichard
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - P Nicolaï
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - E d'Humières
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| | - M Frank
- Department of Mathematics, Center for Engineering Computational Science, RWTH Aachen University, Aachen, Germany
| | - V Tikhonchuk
- CELIA Centre des Lasers Intenses et Applications, University of Bordeaux CNRS CEA, Talence F-33400, France
| |
Collapse
|
21
|
Natale R, Doyen J, Courdi A, Gérard JP, Leysalle A, Dejean C, Feuillade J, Gauthier M, Bénézéry K. Efficacité et toxicité de la radiothérapie de contact par photons de 50kV des carcinomes palpébraux. Cancer Radiother 2015. [DOI: 10.1016/j.canrad.2015.07.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Troussier I, Huguet F, Servagi-Vernat S, Benahim C, Khalifa J, Darmon I, Ortholan C, Krebs L, Dejean C, Fenoglietto P, Vieillot S, Bensadoun RJ, Thariat J. Place de l’arcthérapie modulée et de la chimiothérapie concomitante dans la prise en charge des cancers du canal anal localement évolués. Cancer Radiother 2015. [DOI: 10.1016/j.canrad.2015.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Feuillade J, Gautier M, Dejean C, Mana A, Hannoun–Levi J, Marcie S. New radioisotopes HDR brachytherapy dose. Phys Med 2014. [DOI: 10.1016/j.ejmp.2014.10.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
24
|
Dejean C, Chabaud F, Pigeot E, Bouet R, Richard D, Levy-Chavagnat D. Évolution des pratiques de prescription des benzodiazépines et apparentés. Qu’en est-il de leur association ? Eur Psychiatry 2014. [DOI: 10.1016/j.eurpsy.2014.09.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
IntroductionL’utilisation prolongée et les associations de benzodiazépines (BZD) anxiolytiques et hypnotiques exposent à des risques à court et long terme (dépendance, démence, troubles psychomoteurs…). Selon la Haute Autorité de santé (HAS), il n’y a pas lieu d’associer une BZD et un apparenté (zopiclone ou zolpidem) le soir.Objectifs– Évaluer les habitudes de prescription des BZD et de leurs apparentés hypnotiques dans une population de patients suivis en psychiatrie hospitalière.– Suivre sur 6 années l’évolution de ces pratiques de prescription et l’émergence d’alternatives thérapeutiques aux BZD.– Établir un parallèle avec les recommandations et les actualités de la littérature au sujet de ces risques pendant cette même période.MéthodeL’étude rétrospective a été réalisée au centre hospitalier Henri-Laborit (Poitiers) en sélectionnant les ordonnances informatisées comportant des BZD et/ou apparentés sur une période allant du 1er janvier 2008 au 31 décembre 2013, par tranche d’une année. Les associations de ces molécules et leurs posologies ont été répertoriées.RésultatsL’analyse de 6511 ordonnances a notamment mis en évidence que la prescription de zolpidem ou zopiclone seuls, sans association à une benzodiazépine, est majoritaire (77,5 % des ordonnances en moyenne) jusqu’en 2010. Puis elle diminue fortement (plus que 38 % en 2013) et elle est inférieure à celle de benzodiazépine seule pendant les 3 années suivantes. Parallèlement, le nombre total d’ordonnances dans cet hôpital est en constante augmentation. L’association de benzodiazépine et d’apparentés sur une même ordonnance reste peu courante, dans 2 % des prescriptions en moyenne, mais la prise des deux se situe le soir dans 91 % des cas (69–100 %).ConclusionL’étude montre une diminution de prescription d’hypnotiques apparentés aux BZD, allant de pair avec les mises en garde sur leurs effets indésirables et aux actions de l’HAS. Leur association en soirée à des BZD reste présente et une étude prospective auprès des prescripteurs pour connaître leur choix d’alternative thérapeutique est nécessaire.
Collapse
|
25
|
Dejean C, Boraud T, Le Moine C. Opiate dependence induces network state shifts in the limbic system. Neurobiol Dis 2013; 59:220-9. [PMID: 23911767 DOI: 10.1016/j.nbd.2013.07.012] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2013] [Revised: 05/28/2013] [Accepted: 07/17/2013] [Indexed: 10/26/2022] Open
Abstract
Among current theories of addiction, hedonic homeostasis dysregulation predicts that the brain reward systems, particularly the mesolimbic dopamine system, switch from a physiological state to a new "set point." In opiate addiction, evidence show that the dopamine system principal targets, prefrontal cortex (PFC), nucleus accumbens (NAC) and basolateral amygdala complex (BLA) also adapt to repeated drug stimulation. Here we investigated the impact of chronic morphine on the dynamics of the network of these three interconnected structures. For that purpose we performed simultaneous electrophysiological recordings in freely-moving rats subcutaneously implanted with continuous-release morphine pellets. Chronic morphine produced a shift in the network state underpinned by changes in Delta and Gamma oscillations in the LFP of PFC, NAC and BLA, in correlation to behavioral changes. However despite continuous stimulation by the drug, an apparent normalization of the network activity and state occurred after 2 days indicating large scale adaptations. Blockade of μ opioid receptors was nonetheless sufficient to disrupt this acquired new stability in morphine-dependent animals. In line with the homeostatic dysregulation theory of addiction, our study provides original direct evidence that the PFC-NAC-BLA network of the dependent brain is characterized by a de novo balance for which the drug of abuse becomes the main contributor.
Collapse
Affiliation(s)
- C Dejean
- University of Bordeaux, INCIA, UMR 5287, F-33000 Bordeaux, France; CNRS, INCIA, UMR 5287, F-33000 Bordeaux, France
| | | | | |
Collapse
|
26
|
Boutevin F, Feuillade J, Gautier M, Diagne M, Dejean C. Influence of the collimator rotation and the position of the isocenter on quality controls of treatment plans in dynamic arctherapy. Phys Med 2013. [DOI: 10.1016/j.ejmp.2013.08.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
27
|
|
28
|
Ferré M, Mailleux H, Pierrat N, Dejean C. Calcul de la distribution de dose en curiethérapie. Cancer Radiother 2013; 17:89-92. [DOI: 10.1016/j.canrad.2013.01.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2013] [Accepted: 01/15/2013] [Indexed: 10/27/2022]
|
29
|
Caron J, Feugeas J, Kantor G, Dejean C, Dubroca B, Nicolaï P, Santos J, D'Humières E, Tikhonchuk V. EP-1191: Study and validation of a deterministic model for energetic particles transport. Application in radiotherapy. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33497-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Hannoun-Levi J, Hijazi H, Chand-Fouche M, Gal J, Feuillade J, Dejean C. Early Toxicity Comparison of 3 Different Brachytherapy Boost Fractionation Schemes for Prostate Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Hijazi H, Chand-Fouche M, Gal J, Gauthier M, Dejean C, Hannoun-Levi J. PO-183 PROSTATE CANCER BOOST USING HDR BRACHYTHERAPY: LEARNING CURVE ANALYSIS AFTER 103 CONSECUTIVE PATIENTS. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)72149-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Sargos P, Dejean C, figueiredo BHD, Bui BNG, Italiano A, Stoeckle E, Kantor G. EP-1275 HIGH LEVEL PRE-OPERATIVE HELICAL TOMOTHERAPY (54 GY) FOR RETROPERITONEAL LIPOSARCOMA. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71608-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
33
|
Haddad H, Dejean C, Henriques de Figueiredo B, Sargos P, Caron J, Stoeckle E, Bui BN, Italiano A, Gille O, Kantor G. Expérience de l’institut Bergonié à propos de 14 cas de tomothérapie hélicoïdale de tumeurs axiales et para-axiales. Cancer Radiother 2011; 15:404-12. [DOI: 10.1016/j.canrad.2011.03.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Revised: 03/03/2011] [Accepted: 03/07/2011] [Indexed: 11/25/2022]
|
34
|
Dejean C, Feuillade J, Gautier M, Marcié S. 1379 poster STUDY OF THE NEW SOFTWARE “3DVH(tm)” FOR HEAD AND NECK CASES. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71501-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Gaundong Mbéthé GL, Dejean C, Henriques de Figueiredo B, Sargos P, Italiano A, Kantor G. [Multifocal Langerhans cell histiocytosis of bone: indications for radiotherapy]. Cancer Radiother 2010; 14:759-62. [PMID: 20674449 DOI: 10.1016/j.canrad.2010.03.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2010] [Revised: 01/22/2010] [Accepted: 03/24/2010] [Indexed: 10/19/2022]
Abstract
Langerhans cell histiocytosis is a non-malignant proliferative disease of unknown etiology that can affect one or more organs. This is a rare disease, 1 to 2/100,000, affecting mainly children with a male predominance. The osseous lesions are the most frequent (60 to 90%). There is however no consensus treatment for the management of these sites. We report the cases of two patients successfully treated with radiotherapy after primary chemotherapy, at doses of 15 Gy in ten sessions of 1.5 Gy for one patient and 18 Gy in ten fractions of 1.8 Gy for the other. Single or multifocal bone Langerhans cell histiocytosis without visceral involvement is a benign, self-limiting affection in most cases. Some bone lesions could be treated by radiotherapy alone. But the high variability of doses currently given in the literature does not allow determining the lowest effective dose limiting the risk of secondary neoplasia or impaired growth in children, in whom lower doses of 6 to 8 Gy are recommended. The decision of radiotherapy must be weighed against the risk of the disease. Caution should be the rule in this non-malignant tumour pathology.
Collapse
Affiliation(s)
- G-L Gaundong Mbéthé
- Service de radiothérapie, centre régional de lutte contre le cancer, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France.
| | | | | | | | | | | |
Collapse
|
36
|
Sargos P, Mamou N, Dejean C, Figueiredo BHD, Huchet A, Italiano A, Kantor G. Dose de tolérance à l’irradiation des tissus sains : l’os chez l’adulte. Cancer Radiother 2010; 14:386-91. [DOI: 10.1016/j.canrad.2010.02.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2010] [Accepted: 02/25/2010] [Indexed: 10/19/2022]
|
37
|
Briassoulis D, Hiskakis M, Scarascia G, Picuno P, Delgado C, Dejean C. Labeling scheme for agricultural plastic wastes in Europe. Quality Assurance and Safety of Crops & Foods 2010. [DOI: 10.1111/j.1757-837x.2010.00061.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Haddad H, Thomas L, Floquet A, Guyon F, Belhomme S, Chemin A, Caron J, Dejean C, Kantor G, Richaud P. Tomothérapie hélicoïdale étendue et chimiothérapie concomitante pour un cancer du col de l’utérus : paramètres dosimétriques et toxicité hématologique. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
39
|
Henriques de Figueiredo B, Dejean C, Amsellem E, Caron J, Galland S, Lagarde P, Richaud P, Kantor G. Comparaison dosimétrique entre RCMI dynamique et tomothérapie hélicoïdale pour des cancers de la tête et du cou. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.08.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Dejean C, Caron J, Henrigues De Figueiredo B, Dumas PY, Amsellem E, Lagarde P, Kantor G. Utilisation du logiciel de planification adaptive de tomothérapie : cas d’un cancer de l’amygdale. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.08.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
41
|
Henriques de Figueiredo B, Barret O, Galland S, Demeaux H, Lagarde P, Dejean C, Buj S, Richaud P, Allard M, Fernandez P. Comparaison des volumes cibles définis par scanographie et TEP- au [18F]-FDG pour la radiothérapie des cancers de la tête et du cou. Cancer Radiother 2009. [DOI: 10.1016/j.canrad.2009.08.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
42
|
Donnay L, Dejean C, Amsellem E, Bourezgui H, de Figueiredo B, Duparc A, Caron J, Tournat H, Lagarde P, Stoeckle E, Kantor G. Radiothérapie postopératoire des sarcomes des tissus mous des extrémités. Étude dosimétrique préliminaire comparative de la radiothérapie conformationnelle avec la tomothérapie hélicoïdale. Cancer Radiother 2008; 12:809-16. [DOI: 10.1016/j.canrad.2008.08.275] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2007] [Revised: 07/29/2008] [Accepted: 08/06/2008] [Indexed: 10/21/2022]
|
43
|
Dejean C, Donnay L, Amsellem E, Bourezgui H, Belhomme S, Caron J, Chemin A, Kantor G. Radiothérapie postopératoire des sarcomes des tissus mous des extrémités : étude dosimétrique comparative de la radiothérapie avec et sans modulation d’intensité avec la tomothérapie hélicoïdale. Cancer Radiother 2008. [DOI: 10.1016/j.canrad.2008.08.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
44
|
Mervoyer A, Dejean C, Lisbona A, Amsellem E, Duparc A, Guillaume N, Kantor G, Mahé M. Tomothérapie hélicoïdale craniospinale chez l’adulte : faisabilité et comparaison dosimétrique avec une technique conventionnelle. Cancer Radiother 2008. [DOI: 10.1016/j.canrad.2008.08.243] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
45
|
Kantor G, Laprie A, Huchet A, Loiseau H, Dejean C, Mazeron JJ. [Radiation therapy for glial tumors: technical aspects and clinical indications]. Cancer Radiother 2008; 12:687-94. [PMID: 18926759 DOI: 10.1016/j.canrad.2008.09.004] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Radiotherapy of glial tumors is rapidly evolving with the recent technical and therapeutic progress. About technical aspects, progress in technical imaging and development of non-coplanar conformal and IMRT techniques provide new possibilities for sparing healthy tissue while increasing dose in tumoral volume. Furthermore, functional and molecular imaging are helpful for delineation and for prediction of relapse. Even modest, the actual improvement of survival with radiochemotherapy leads now to new and important developments for clinical research according to clinical data (age, general status), biological data (MGMT promotor methylation and cytogenetic modifications) and technical data (quality of surgery and radiotherapy). Understanding of molecular mechanisms allows for rational targeting or specific pathways of repair, signaling angiogenesis associated with surgery and radiotherapy in a multidisciplinary approach.
Collapse
Affiliation(s)
- G Kantor
- Service de radiothérapie, centre régional de lutte contre le cancer, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France.
| | | | | | | | | | | |
Collapse
|
46
|
Resano M, Esteban E, González-Pérez E, Vía M, Athanasiadis G, Avena S, Goicoechea A, Bartomioli M, Fernández V, Cabrera A, Dejean C, Carnese F, Moral P. How many populations set foot through the Patagonian door? Genetic composition of the current population of Bahía Blanca (Argentina) based on data from 19 Alu polymorphisms. Am J Hum Biol 2008; 19:827-35. [PMID: 17876811 DOI: 10.1002/ajhb.20648] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The city of Bahía Blanca occupies a strategic place in Argentina south of the Pampean region in the north-east corner of the Patagonia. Since 1828, this city has been the historical and political border between Amerindian lands in the south, and the lands of European colonists. Nowadays, Bahía Blanca is an urban population mainly composed by descendents of immigrants from Spain and other European countries with apparently low admixture with Amerindians. In view of the unexpectedly high Amerindian admixture levels (about 46.7%) suggested by mtDNA data, and protein markers (19.5%), we analyzed a set of 19 Alu polymorphisms (18 autosomal, 1 of Chromosome Y) in a well-documented genealogical sample from Bahía Blanca. The genotyped sample was made up of 119 unrelated healthy individuals whose birth place and grandparent origins were fully documented. According to available genealogical records, the total sample has been subdivided into two groups: Bahía Blanca Original (64 individuals with all 4 gandparents born in Argentina) and Bahía Blanca Mix (55 individuals with one to three grandparents born out of Argentina). Allele frequencies and gene diversity values in Bahía Blanca fit well into the European ranges. Population relationships have been tested for 8 Alu markers, whose variation has been described in several Amerindian and European samples. Reynolds genetic distances underline the significant genetic similarity of Bahía Blanca to Europeans (mean distance 0.044) and their differentiation from Amerindians (0.146). Interestingly enough, when the general sample is divided, Bahía Blanca Original appears slightly closer to Amerindians (0.127) in contrast to Bahía Blanca Mix (0.161). Furthermore, the genetic relationships depicted through a principal components analysis emphasize the relative similarity of Bahía Blanca Original to Amerindians. A thorough knowledge of the sample origins has allowed us to make a subtle distinction of the genetic composition of Bahía Blanca.
Collapse
Affiliation(s)
- M Resano
- Unitat d'Antropologia, Departament de Biologia Animal, Universitat de Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Tournat H, Dejean C, Caron J, Richaud P. Comparaison dosimétrique d'une planification deRCMI IMRT etd'unetomothérapie danslecadre dutraitement d'un lymphome orbitaire. Cancer Radiother 2007. [DOI: 10.1016/j.canrad.2007.09.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
48
|
Kantor G, Dejean C, Duparc A, Giraud P, Zefkili S, Mazal A, Mahé M, Lisbona A. Tomothérapie: mise enplace d'une plateforme commune pourlapréparation etl'évaluation destraitements, laP2E. Cancer Radiother 2007. [DOI: 10.1016/j.canrad.2007.09.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
49
|
Caron J, Dejean C, Chemin A, Belhomme S. Adaptation delaradioprotection d'un bunker deradiothérapie pouraccueillir unappareil detomothérapie hélicoïdale. Cancer Radiother 2007. [DOI: 10.1016/j.canrad.2007.09.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
50
|
Kantor G, Mahé MA, Giraud P, Alapetite C, Durdux C, Fourquet A, Gardner M, Le Prisé E, Maire JP, Richaud P, Vendrely V, Caron J, Dejean C, Lisbona A, Munos C, Zefkili S, Mazal A. Évaluation nationale de la tomothérapie hélicoïdale: description des indications, des contraintes de dose et des seuils de repositionnement. Cancer Radiother 2007; 11:331-7. [PMID: 17962061 DOI: 10.1016/j.canrad.2007.09.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- G Kantor
- Service de Radiothérapie, Institut Bergonié, 229, Cours de l'Argonne, 33076, Bordeaux Cedex, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|